Slow-release oral morphine (SROM)

As of June 5, Kadian® (SROM) was covered for use in opioid-assisted treatment (OAT), in addition to being used for pain.

To ensure accurate medication profiles, the correct indication must be written on the prescription, i.e. “for pain” or “for OAT.” Clearly indicate “daily witnessed ingestion” or “daily dispense” on the prescription if SROM is being used for OAT and ingestion must be witnessed. Identifying the intended use ensures patient safety and allows the prescription to be billed properly through PharmaNet.